Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 185 Results

Intervention Indication Therapeutic Area Year Actions
Tolebrutinib for treating relapsing multiple sclerosis Tolebrutinib (PRN-2246;SAR-442168) Multiple sclerosis (MS) Neurology 2023 View  |  Download
Topical rapamycin cream for treating facial angiofibroma Topical rapamycin cream Facial angiofibroma Cardiovascular System , Dermatology , Genetic Disorders 2023 View  |  Download
Toripalimab in combination with paclitaxel and cisplatin for treating advanced or metastatic oesophageal squamous cell cancer without previous systemic chemotherapy Cisplatin (Platinol) , Paclitaxel (Taxol; paclitaxel albumin) , Toripalimab Head and Neck Cancer 2023 View  |  Download
Toripalimab with chemotherapy for previously untreated recurrent or metastatic nasopharyngeal carcinoma Chemotherapy , Toripalimab Nasopharyngeal carcinoma Head and Neck Cancer 2023 View  |  Download
TransCon PTH for treating hypoparathyroidism TransCon PTH Hypoparathyroidism Endocrine Nutritional and Metabolic Disorders 2023 View  |  Download
Trastuzumab deruxtecan neoadjuvant therapy for high-risk HER2-positive early stage breast cancer Trastuzumab deruxtecan (DS-8201a; Enhertu) Breast cancer Breast Cancer 2023 View  |  Download
Trastuzumab duocarmazine for third-line treatment of HER2-positive unresectable metastatic breast cancer Trastuzumab duocarmazine Breast cancer Breast Cancer 2023 View  |  Download
Tucatinib with trastuzumab and pertuzumab for maintenance treatment of unresectable locally advanced or metastatic HER2-positive breast cancer Pertuzumab (Perjeta; R-1273) , Trastuzumab (Herceptin; RG-597) , Tucatinib (ONT-380) Breast cancer Breast Cancer 2023 View  |  Download
Upadacitinib for treating giant cell arteritis Upadacitinib (ABT-494; Rinvoq; upadacitinib hemihydrate) Giant cell arteritis Cardiovascular System 2023 View  |  Download
Ustekinumab for the treatment of moderately to severely active Crohn's disease in children Ustekinumab (Stelara; CNTO 1275; CNTO-1275) Crohn's disease Gastroenterology , Immunology 2023 View  |  Download
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications